Lipid Mediators in Cardiovascular Physiology and Disease

Review
In: Cardiovascular Signaling in Health and Disease [Internet]. Cham (CH): Springer; 2022.
.

Excerpt

Bioactive lipids have taken the center stage in the last decade as dynamic mediators of cellular signaling and regulation. Lipids can directly and indirectly modify cellular processes that are independent from their utilization as fuel or structural properties. Among those processes, bioactive lipids are strong mediators of both cardiac and vascular function through diverse mechanisms. One family of lipids includes oxylipins, lipids derived from 𝜔-3 and 𝜔-6 fatty acids such as arachidonic and linoleic acids. Oxylipins play an essential role in whole-body physiology and function including maintenance of cardiac health and vascular homeostasis through direct and indirect mechanisms such as oxylipin receptors or regulation of inflammation. Overactivation or chronic stimulation of oxylipin synthesis has been linked to atherosclerosis, endothelial dysfunction, fibroblast overactivation, myocardial dysfunction, and immune cell activation. Thus, oxylipins are important lipid mediators of cardiovascular physiology and disease.

Publication types

  • Review